Jonathan Corren

Summary

Affiliation: UCLA School of Medicine
Country: USA

Publications

  1. ncbi Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure
    Tamara T Perry
    Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ann Allergy Asthma Immunol 93:431-8. 2004
  2. ncbi The connection between allergic rhinitis and bronchial asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Curr Opin Pulm Med 13:13-8. 2007
  3. doi Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
    Jonathan Corren
    Allergy Medical Clinic, 10780 Santa Monica Blvd, Suite 280, Los Angeles, CA 90025, USA
    Respir Med 107:180-95. 2013
  4. doi The relationship of rhinitis and asthma, sinusitis, food allergy, and eczema
    Ricardo A Tan
    California Allergy and Asthma Medical Group, 11645 Wilshire Boulevard, Suite 1155, Los Angeles, CA 90025, USA
    Immunol Allergy Clin North Am 31:481-91. 2011
  5. ncbi Asthma phenotypes and endotypes: an evolving paradigm for classification
    Jonathan Corren
    Section of Clinical Immunology and Allergy, Department of Medicine, University of California, Los Angeles, 10780 Santa Monica Blvd, Suite 280, Los Angeles, California 90025, USA
    Discov Med 15:243-9. 2013
  6. ncbi Evaluation and treatment of asthma: an overview
    Jonathan Corren
    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Am J Manag Care 11:S408-15; quiz S427-33. 2005
  7. doi Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma
    Michelle Zeidler
    David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Curr Med Res Opin 26:1295-305. 2010
  8. doi Lebrikizumab treatment in adults with asthma
    Jonathan Corren
    Allergy Medical Clinic, Los Angeles, California, USA
    N Engl J Med 365:1088-98. 2011
  9. doi Anti-interleukin-5 antibody therapy in asthma and allergies
    Jonathan Corren
    Allergy Medical Clinic, Los Angeles, California, USA
    Curr Opin Allergy Clin Immunol 11:565-70. 2011
  10. ncbi Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis
    Christina Lee
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Section of Clinical Immunology and Allergy, University of California, Los Angeles, Los Angeles, CA, USA
    Expert Opin Pharmacother 8:701-9. 2007

Detail Information

Publications34

  1. ncbi Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure
    Tamara T Perry
    Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ann Allergy Asthma Immunol 93:431-8. 2004
    ..Challenge with short-term exposure to airborne cat allergen in sensitized patients produces pulmonary function changes and rhinitis symptoms...
  2. ncbi The connection between allergic rhinitis and bronchial asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Curr Opin Pulm Med 13:13-8. 2007
    ..The relationship between allergic rhinitis and asthma has intrigued practicing physicians since the turn of the century. Investigations during the past two decades have led to an increased understanding of this relationship...
  3. doi Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
    Jonathan Corren
    Allergy Medical Clinic, 10780 Santa Monica Blvd, Suite 280, Los Angeles, CA 90025, USA
    Respir Med 107:180-95. 2013
    ..i.d.) via a single aerosol inhaler, with the individual components (fluticasone 250 μg b.i.d.; formoterol 10 μg b.i.d.), in adult and adolescent patients with moderate-to-severe asthma...
  4. doi The relationship of rhinitis and asthma, sinusitis, food allergy, and eczema
    Ricardo A Tan
    California Allergy and Asthma Medical Group, 11645 Wilshire Boulevard, Suite 1155, Los Angeles, CA 90025, USA
    Immunol Allergy Clin North Am 31:481-91. 2011
    ..Allergic rhinitis and asthma are now increasingly being approached diagnostically and therapeutically as the one-airway concept...
  5. ncbi Asthma phenotypes and endotypes: an evolving paradigm for classification
    Jonathan Corren
    Section of Clinical Immunology and Allergy, Department of Medicine, University of California, Los Angeles, 10780 Santa Monica Blvd, Suite 280, Los Angeles, California 90025, USA
    Discov Med 15:243-9. 2013
    ....
  6. ncbi Evaluation and treatment of asthma: an overview
    Jonathan Corren
    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Am J Manag Care 11:S408-15; quiz S427-33. 2005
    ..Asthma is a chronic, inflammatory condition that requires diligent long-term follow-up. This article will address the diagnostic evaluation of patients with asthma and present an overview of drugs commonly used in treatment...
  7. doi Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma
    Michelle Zeidler
    David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Curr Med Res Opin 26:1295-305. 2010
    ..Mometasone furoate delivered via a dry powder inhaler (MF-DPI) is indicated for once-daily maintenance treatment of asthma in patients as young as 4 years old...
  8. doi Lebrikizumab treatment in adults with asthma
    Jonathan Corren
    Allergy Medical Clinic, Los Angeles, California, USA
    N Engl J Med 365:1088-98. 2011
    ..We hypothesized that anti-interleukin-13 therapy would benefit patients with asthma who had a pretreatment profile consistent with interleukin-13 activity...
  9. doi Anti-interleukin-5 antibody therapy in asthma and allergies
    Jonathan Corren
    Allergy Medical Clinic, Los Angeles, California, USA
    Curr Opin Allergy Clin Immunol 11:565-70. 2011
    ....
  10. ncbi Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis
    Christina Lee
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Section of Clinical Immunology and Allergy, University of California, Los Angeles, Los Angeles, CA, USA
    Expert Opin Pharmacother 8:701-9. 2007
    ..Given its unique pharmacologic properties and clinical profile, azelastine maintains an important role in the treatment of chronic rhinitis...
  11. ncbi Small airways disease in asthma
    Jonathan Corren
    Allergy Research Foundation, University of California, Los Angeles, 11620 Wilshire Boulevard 200, Los Angeles, CA 90025, USA
    Curr Allergy Asthma Rep 8:533-9. 2008
    ..The recognition of small airways involvement in asthma has clinical relevance, as new formulations of inhaled corticosteroids with smaller particle aerosols may be more effective in addressing this component of asthma...
  12. doi A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    Am J Respir Crit Care Med 181:788-96. 2010
    ..AMG 317 is a fully human monoclonal antibody to IL-4Ralpha that blocks both IL-4 and IL-13 pathways...
  13. ncbi Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    Clin Ther 29:823-43. 2007
    ....
  14. doi Role of interleukin-13 in asthma
    Jonathan Corren
    Department of Medicine, Section of Clinical Immunology and Allergy, University of California, 10780 Santa Monica Blvd, Suite 280, Los Angeles, CA, 90025, USA
    Curr Allergy Asthma Rep 13:415-20. 2013
    ..These data indicate that IL-13 antagonists may fulfill an important unmet need in patients with poorly controlled asthma and biologic evidence of persistent IL-13 activity. ..
  15. doi Omalizumab in the treatment of asthma
    Ricardo Tan
    California Allergy and Asthma Medical Group Inc, 11645 Wilshire Boulevard, Suite 1155, Los Angeles, CA 90025, USA
    Expert Rev Respir Med 5:747-56. 2011
    ..In our opinion, omalizumab is well-tolerated and significantly improves pulmonary function, decreases clinical symptoms and improves the quality of life in patients with uncontrolled allergic asthma...
  16. pmc Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, USA
    Nutr J 7:20. 2008
    ..The current study was conducted to determine the effects of these combined ingredients upon the nasal response to allergen challenge in patients with seasonal allergic rhinitis...
  17. doi Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge
    Jonathan Corren
    Allergy Medical Clinic, Research Division, Los Angeles, CA, USA
    J Allergy Clin Immunol 127:398-405. 2011
    ..Environmental exposure to cat allergen is common, and sensitization to cat allergens is strongly associated with asthma...
  18. doi Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 121:506-11. 2008
    ..It is not known whether stopping or reducing the dose of omalizumab maintains adequate suppression of free IgE levels and IgE-mediated mast cell activation...
  19. ncbi Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90025, USA
    Clin Ther 27:543-53. 2005
    ..Azelastine nasal spray and oral cetirizine are selective histamine H(1)-receptor antagonists that are approved in the United States for the treatment of seasonal allergic rhinitis (SAR)...
  20. ncbi Relationship between nonallergic upper airway disease and asthma
    Jonathan Corren
    Department of Medicine, University of California, Los Angeles, California, USA
    Clin Allergy Immunol 19:101-14. 2007
    ..Finally, given this complex relationship between localized and systemic inflammation, it behooves all physicians to assess and treat rhinitis and sinusitis when they are present in patients with asthma...
  21. ncbi Rhinitis therapy and the prevention of hospital care for asthma: a case-control study
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 113:415-9. 2004
    ..Although clinical trials have demonstrated that rhinitis therapy improves subjective and objective measures of asthma, it is uncertain whether treatment of allergic rhinitis significantly affects the frequency of asthma exacerbations...
  22. ncbi Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma
    Michelle Zeidler
    Department of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California 90025, USA
    Treat Respir Med 3:35-44. 2004
    ..Future studies, involving histopathologic and clinical endpoints, will be necessary to determine whether treatment with HFA solutions offers significant advantages over currently available therapies...
  23. doi Safety of omalizumab in asthma
    Ricardo A Tan
    California Allergy and Asthma Medical Group, 11645 Wilshire Blvd, Suite 1155, Los Angeles, CA 90025, USA
    Expert Opin Drug Saf 10:463-71. 2011
    ..There is still understandable concern regarding the long-term effects of this drug...
  24. doi Cytokine inhibition in severe asthma: current knowledge and future directions
    Jonathan Corren
    Research Division, Allergy Medical Clinic, Los Angeles, California 90025, USA
    Curr Opin Pulm Med 17:29-33. 2011
    ..Existing data from clinical trials of cytokine antagonists in asthmatic patients are then reviewed to determine the efficacy and safety of these compounds...
  25. ncbi Budesonide/formoterol in the treatment of asthma
    Christina Lee
    Department of Medicine, Division of Allergy and Immunology, VA Greater Los Angeles Healthcare System University of California Los Angeles, Los Angeles, CA, USA
    Expert Rev Respir Med 2:551-64. 2008
    ..Use of this approach has resulted in studies evaluating SMART, demonstrating significantly lower rates of exacerbations and reliever medication use compared with fixed-dosing regimens in asthma...
  26. ncbi Immunomodulation of asthma: where do we stand?
    Jonathan Corren
    Allergy Research Foundation, 11620 Wilshire Boulevard, Suite 200 210, Los Angeles, CA 90025, USA
    Curr Allergy Asthma Rep 2:433-5. 2002
  27. ncbi Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, Calif 90025, USA
    J Allergy Clin Immunol 111:87-90. 2003
    ..Prevention of serious asthma exacerbations is an important therapeutic goal in patients with asthma...
  28. ncbi Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90023, USA
    Clin Ther 25:776-98. 2003
    ..HFA replaces the chlorofluorocarbon (CFC) propellant of the previous formulation, producing aerosols of smaller average particle size...
  29. ncbi Small airways response to naturalistic cat allergen exposure in subjects with asthma
    Michelle R Zeidler
    Division of Pulmonary, David Geffen School of Medicine and Allergy Research Foundation, University of California, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 118:1075-81. 2006
    ..It is currently unclear whether the small airways (diameter <2 microm) contribute significantly to late asthmatic reactions to inhaled allergen...
  30. doi A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects
    Kenneth Tripp
    Sepracor, Inc, Marlborough, MA 01752, USA
    J Allergy Clin Immunol 122:544-9. 2008
    ..The short-acting beta(2)-agonists levalbuterol and racemic albuterol are available for administration through a hydrofluoroalkane-134a (HFA) metered-dose inhaler (MDI)...
  31. ncbi Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine
    Craig F LaForce
    Carolina Allergy and Asthma Consultants, Raleigh, North Carolina 27607, USA
    Ann Allergy Asthma Immunol 93:154-9. 2004
    ..Currently available oral second-generation antihistamines do not provide adequate symptom relief for many allergy patients...
  32. ncbi The rhinitis-asthma link revisited
    Jonathan Corren
    Ann Allergy Asthma Immunol 94:311-2. 2005
  33. ncbi Nasal response to natural cat allergen exposure is significantly greater in patients with rhinitis and asthma than in patients with rhinitis alone
    Jonathan Corren
    J Allergy Clin Immunol 115:202-3. 2005
  34. ncbi Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion
    Eric Schenkel
    Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Allergy Asthma Proc 23:325-30. 2002
    ..It was concluded that desloratadine/pseudoephedrine offers additional benefit to patients with moderate-to-severe SAR-associated nasal congestion compared with pseudoephedrine therapy alone...